Dolby Laboratories Inc. A Stock
There is an upward development for Dolby Laboratories Inc. A compared to yesterday, with an increase of €0.65 (1.240%).
With 10 Buy predictions and not the single Sell prediction the community is currently very high on Dolby Laboratories Inc. A.
As a result the target price of 82 € shows a very positive potential of 54.72% compared to the current price of 53.0 € for Dolby Laboratories Inc. A.
Pros and Cons of Dolby Laboratories Inc. A in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dolby Laboratories Inc. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dolby Laboratories Inc. A | 1.240% | -0.286% | -5.676% | -19.462% | -6.518% | -32.712% | -38.950% |
| Roku | 0.400% | 3.803% | 9.358% | 65.530% | -6.769% | 53.288% | -72.910% |
| Alibaba Pictures Group Ltd | -2.980% | -5.522% | -8.921% | 14.054% | -31.568% | 8.205% | -38.544% |
| Imax China Holding Inc | -1.230% | -1.220% | -0.613% | 22.727% | -7.955% | -10.497% | -54.749% |
Comments
Dolby Laboratories (NYSE:DLB) had its "buy" rating reaffirmed by analysts at Rosenblatt Securities. They now have a $85.00 price target on the stock.
Show more
Ratings data for DLB provided by MarketBeat
Dolby Laboratories (NYSE:DLB) had its price target lowered by analysts at Barrington Research from $95.00 to $90.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for DLB provided by MarketBeat
Dolby Laboratories (NYSE:DLB) had its "buy" rating reaffirmed by analysts at Rosenblatt Securities. They now have a $85.00 price target on the stock.
Show more
Ratings data for DLB provided by MarketBeat
News
Dolby Stock Down 18%, Yet This $8 Million Bet Signals Turnaround Potential
On February 13, 2026, Neo Ivy Capital Management disclosed a new position in Dolby Laboratories (NYSE:DLB), acquiring 117,964 shares in a trade estimated at $7.58 million.
Neo Ivy Capital Management
Is Dolby Stock a Buy or Sell After the CEO Sold Shares Worth $2.5 Million?
President and CEO Kevin J. Yeaman executed an option exercise and immediate sale of 36,699 shares of Dolby Laboratories (NYSE:DLB) on November 24, 2025; see SEC Form 4 filing.
Transaction value
Dolby Laboratories: A Strong Player in Audio Technology with Promising Potential
Explore the exciting world of Dolby Laboratories (NYSE: DLB) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into